New Delhi: India plans to increase the production of combat medicines, including drugs to treat burns, blood replenishers for treatment of trauma injuries such as gunshot wounds, and orthopedic implants. The Department of Pharmaceuticals has been tasked to come up with a list of such medicines and ensure an increase in their production to mitigate…
Discussions focused on bringing Indian duties on US products in line with the tariff levels imposed by the US on Indian goods. In return, India sought relief from US compliance burden on shrimp, processed food items, pharmaceuticals, and chemicals, among others, the people cited above said on the condition of anonymity. A US delegation led…
The US-India economic partnership is the envy of many. But our joint mission of achieving $500 billion in bilateral trade by 2030 stands on shaky ground. US President Donald Trump’s reciprocal tariff policy, due to come into effect on 2 April, has upset global markets and will strain our trade relations. India must keep its…
New Delhi: The government has sought expressions of interest (EoI) for research & development (R&D) projects to develop novel technologies in medicine, including medical devices and drugs for communicable and non-communicable diseases. The focus will be on drug discovery for hypertension, lung disease, cancer, diabetes and rare diseases. The EoIs have been floated by the…
To be sure, progress on India’s FTA with the European Union has not been insubstantial. Both sides have committed themselves to signing it by the end of this calendar year. When it happens, it will be the world’s largest deal of its kind. A trade pact between both sides will not just strengthen our trade…
